Research programme: antifungals - Celltech Group

Drug Profile

Research programme: antifungals - Celltech Group

Alternative Names: Antifungals research programme - Celltech Group; Peptide mannosyl transferase I inhibitors research programme - Celltech Group; PMT-1 inhibitors research programme - Celltech Group; Research programme: peptide mannosyl transferase I inhibitors - Celltech Group; Research programme: PMT-1 inhibitors - Celltech Group

Latest Information Update: 12 Dec 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Celltech Group
  • Class
  • Mechanism of Action Cell wall inhibitors; Peptide mannosyl transferase I inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Mycoses

Most Recent Events

  • 12 Dec 2003 Discontinued - Preclinical for Mycoses in United Kingdom (unspecified route)
  • 08 Dec 2003 The integration of Oxford GlycoSciences into Celltech Group has been completed
  • 31 Jul 2003 Oxford GlycoSciences has been acquired by Celltech Group
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top